COMPANY
Fresenius Kabi USA, LLC
Fresenius Kabi USA, LLC: US labeler, trial sponsor, recalling firm for Calcitonin, Cetrorelix, Daptomycin, Desmopressin, Ganirelix, Glucagon, Icatibant, Octreotide, Oxytocin, Vancomycin, Vasopressin, as stated by public registers.
Also written as: FRESENIUS KABI USA, LLC.
US LABELER
Lists a finished product with FDA (NDC directory); can be a maker, repackager or distributor.
| Calcitonin | Calcitonin Salmon, ANDA Regulator openFDA |
|---|---|
| Cetrorelix | cetrorelix acetate, ANDA Regulator openFDA |
| Daptomycin | Daptomycin, ANDA Regulator openFDA |
| Desmopressin | Desmopressin Acetate, ANDA Regulator openFDA |
| Ganirelix | Ganirelix Acetate, ANDA Regulator openFDA |
| Glucagon | Glucagon, NDA Regulator openFDA |
| Icatibant | Icatibant, ANDA Regulator openFDA |
| Octreotide | Octreotide, ANDA Regulator openFDA |
| Oxytocin | Oxytocin, NDA Regulator openFDA |
| Vancomycin | Vancomycin Hydrochloride, ANDA Regulator openFDA |
| Vancomycin | VANCOMYCIN HYDROCHLORIDE, ANDA Regulator openFDA |
| Vasopressin | VASOPRESSIN, ANDA Regulator openFDA |
TRIAL SPONSOR
Sponsors registered clinical trials of the peptide.
| Glucagon | 1 registered trial Trial register ClinicalTrials.gov |
|---|
RECALLING FIRM
Recalled a product naming the peptide (FDA enforcement report).
| Octreotide | Class II recall, Terminated, 2016-06-01 Regulator openFDA |
|---|---|
| Oxytocin | Class II recall, Terminated, 2013-07-24 Regulator openFDA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.